Home / Companies / Innovent Biologics, Inc. / 24 Jun 2026
Innovent Biologics, Inc.: meeting of 24 Jun 2026
Votes reported on Form N-PX, item by item
104 Form N-PX filers reported votes at the Innovent Biologics, Inc. meeting of 24 Jun 2026. Their records fall into 7 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
3 nominees; 97.2% of reported votes for; 13 filers withheld from or voted against at least one nominee.
546 vote records from 104 filers. 0 of the 103 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
183 vote records from 104 filers. 59 of the 103 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
544 vote records from 104 filers. 77 of the 103 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
COMPENSATIONIssuer
COMPENSATION: management items
Management items in this category are shown together; filers word and number them differently.
182 vote records from 104 filers. 5 of the 103 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
161 vote records from 87 filers. 0 of the 87 filers that marked the item either way voted against management.
OTHERIssuer
OTHER: management items
Management items in this category are shown together; filers word and number them differently.
52 vote records from 17 filers. 0 of the 16 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
Several categoriesSecurity holder
Shareholder proposals (not separable from the filings)
Filers described these proposals in wordings that could not be matched to one another, so they are shown together.
2 vote records from 1 filers. 0 of the 1 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Auditor |
|---|---|---|
| Vanguard | For | For |
| BlackRock and iShares | For | For |
| Fidelity | For | For |
| Dimensional | For | Against * |
| State Street and SPDR | For | Against * |
| American Century | For | Against * |
| Franklin Templeton | For | Against * |
| Invesco | For | Against * |
| Equitable | For | Against * |
| Charles Schwab | For | For |
| Nuveen and TIAA | For | For |
| John Hancock and Manulife | For | Against * |
| Morgan Stanley, Eaton Vance and Calvert | For | Against * |
| J.P. Morgan | For | Against * |
| Goldman Sachs | For | Against * |
| WisdomTree | For | Against * |
| PGIM and Prudential | For | For |
| Jackson National funds | For | Against * |
| Northern Trust and FlexShares | For | Against * |
| SEI | For | For |
| T. Rowe Price | For | For |
| Lincoln Financial | For | Against |
| Voya | For | For |
| Russell Investments | For | For |
| Brighthouse Funds | For | Against |
| BNY Mellon | For | Against * |
| Capital Group and American Funds | For | For |
| Pacific Life funds | For | Against * |
| Hartford Funds | For | For |
| Virtus | For | Against * |
| Neuberger Berman | For | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Innovent Biologics, Inc. meeting?
104 Form N-PX filers reported votes at the meeting of 24 Jun 2026. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Innovent Biologics, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Innovent Biologics, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Innovent Biologics, Inc. with a meeting date within three days of 24 Jun 2026. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.